Arylamidrazones as novel corticotropin releasing factor receptor antagonists

Journal of Medicinal Chemistry

Volumn 45, Issue 11, 2002, Pages 2123-2126

  Wilson, Dean M ^a   Termin, Andreas P ^a   Mao, Long ^a   Ramirez Weinhouse, Michele M ^a   Molteni, Valentina ^a   Grootenhuis, Peter D J ^a   Miller, Keith ^a   Keim, Susan ^a   Wise, Gwendolyn ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 (6 DIMETHYLAMINO 4 METHYL 3 PYRIDINYL) 7 DIPROPYLAMINO 2,5 DIMETHYLPYRAZOLO[1,5 A]PYRIMIDINE; 4 (2 CHLORO 4 METHOXY 5 METHYLPHENYL) N [2 CYCLOPROPYL 1 (3 FLUORO 4 METHYLPHENYL)ETHYL] 5 METHYL N (2 PROPYNYL) 2 THIAZOLAMINE; AMIDRAZONE DERIVATIVE; BUTYL[2,5 DIMETHYL 7 (2,4,6 TRIMETHYLPHENYL) 7H PYRROLO[2,3 D]PYRIMIDIN 4 YL]ETHYLAMINE; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; UNCLASSIFIED DRUG;

ADRENAL INSUFFICIENCY; ANXIETY; ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG POTENCY; DRUG STRUCTURE; HUMAN; RECEPTOR BINDING; STRESS; STRUCTURE ACTIVITY RELATION; STRUCTURE ANALYSIS;

ANILINE COMPOUNDS; ANIMALS; HYDRAZINES; RATS; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 0037161584     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm025512y     Document Type: Article

References (32)

1. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin
2. Recent progress in corticotropin releasing factor receptor agents
3. New developments in the study of corticotropin releasing factor
4. Urocortin II: A member of the corticotropin-releasing factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors
5. Corticotropin releasing factor (CRF) receptor modulators: Progress and opportunities for new therapeutic agents
6. Corticotropin releasing hormone, receptor regulation and the stress response
7. Oral administration of a corticotropin releasing hormone receptor antagonist significantly attenuates behavioral, neuroendocrine, and autonomic responses to stress in primates
8. Are CRF receptor antagonists potential antidepressants?
9. Stress, corticotropin-releasing factor, and drug addiction
10. Role of corticotropin-releasing factor (CRF) receptors in the Anorexic syndrome induced by CRF
11. Neuropeptide abnormalities in anorexia nervosa
12. Corticotropin releasing hormone: Therapeutic implications and medicinal chemistry developments
13. Pharmacaphore development for corticotropin releasing hormone: New insights into inhibitor activity
14. Corticotropin releasing hormone in synovial fluids and tissues of patients with rheumatoid arthritis and osteoarthritis
15. Presence of immunoreactive corticotropin-releasing factor in thyroid lesion
16. 1 receptor: Design of small molecule inhibitors, receptor subtypes, and clinical indications
17. 1 receptor antogonist
18. Chronic administration of the selective corticotropin-releasing factor 1 receptor antagonist CP-154,526: Behavioral, endocrine, and neurochemical effects in the rat
19. Effects of the high-affinity corticotropin releasing hormone receptor 1 antagonist R121919 in major depression: The first 20 patients treated
20. Rapid, reliable drug discovery
21. Non-peptide corticotropin releasing hormone antagonists: Syntheses and structure - Activity relationships of 2-anilinopyrimidines and -triazines
22. 1,3-Dipolar cycloaddition and nucleophilic substitution reactions of C-acetyl and C-ethoxycarbonyl derivative of hydrazidoyl bromides
23. Azo-hydrazone conversion. I. The Japp-Klingemann reaction
24. Heterocycles from nitrile imines. Part IV. Chiral 4,5-dihydro-1,2,4-triazin-6-ones
25. A one step synthesis of benzimidazo-[2,1-c] [1,2,4]triazole derivatives using hydrazonyl bromides